Annexon appoints Dr. Rick Artis as Chief Scientific Officer, succeeding Dr. Larry Mattheakis

Annexon, Inc.

Dean 'Rick' Artis, Ph.D., appointed CSO effective January 6, 2023, succeeding Larry C. Mattheakis who is departing.
Artis previously served as SVP of Chemistry at Annexon and discovered small molecule ANX1502.
Artis most recently was CSO at Octant Bio and has discovery-to-clinic experience across multiple therapeutic areas.
He will lead all research efforts with focus on expanding small molecule pipeline and advancing complement portfolio.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Larry C. Mattheakis

Chief Scientific Officer

ANNX · Annexon, Inc.

Effective: 2023-01-06
Successor: Dean Richard Artis
Filed: January 6, 2023, 6:59 PM ET

Dr. Artis is succeeding Larry C. Mattheakis, Ph.D., who is departing from the Company and is no longer serving as Chief Scientific Officer effective as of January 6, 2023.

Appointed

Dean Richard Artis

Chief Scientific Officer

ANNX · Annexon, Inc.

Effective: 2023-01-06
Filed: January 6, 2023, 6:59 PM ET

the appointment of Dean Richard Artis, Ph.D. as Chief Scientific Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry C. Mattheakis departed as Chief Scientific Officer at Annexon, Inc..

Action: departed
Role: Chief Scientific Officer

Exact text from the filing

Dr. Artis is succeeding Larry C. Mattheakis, Ph.D., who is departing from the Company and is no longer serving as Chief Scientific Officer effective as of January 6, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dean Richard Artis was appointed as Chief Scientific Officer at Annexon, Inc..

Action: appointed
Role: Chief Scientific Officer

Exact text from the filing

the appointment of Dean Richard Artis, Ph.D. as Chief Scientific Officer of the Company.

View on SEC.gov

Annexon, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-002932

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.